Pancreatic Cancer Clinical Trials
The Virginia G.Piper Cancer Center at Scottsdale Healthcare is on one of the original Stand Up To Cancer Dream Teams sites. As the only center in the Southwest participating as a clinical collaborator in the SU2C Pancreatic Cancer Dream Team grant, it conducts clinical trials of new cancer treatments designed to cut off the fuel supply of nutrients feeding pancreatic cancer cells.
Led by Dr. Daniel Von Hoff, Director of TGen’s Clinical Translational Research Division, The Virginia G. Piper Clinical Trials is a partnership between TGen and Scottsdale Healthcare that treats cancer patients with promising new drugs. Its clinical studies have shown encouraging results in improving quality of life and extending life expectancy for patients with advanced stage pancreatic cancer.
Eligible cancer patients who consent to participate in a cancer clinical trial study will receive treatment coordinated by Scottsdale Healthcare Research Institute, located in the Virginia G. Piper Cancer Center. The treatment team may include research physicians, research nurses, data managers and oncologists.
For More Information About Pancreatic Cancer Clinical Trials
Virginia G. Piper Cancer Center
Clinical Trial Patient Care Coordinator
10460 North 92nd Street
Scottsdale, Arizona 85258